Hypermarcas (OTCMKTS:HYPMY – Get Free Report)’s stock price traded up 10.7% during trading on Tuesday . The company traded as high as $4.35 and last traded at $4.35. 2,202 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 19,453 shares. The stock had previously closed at $3.93.
Hypermarcas Stock Performance
The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The stock has a market cap of $2.56 billion, a P/E ratio of 17.57 and a beta of 0.73. The firm’s 50-day moving average is $4.49 and its two-hundred day moving average is $4.42.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
See Also
- Five stocks we like better than Hypermarcas
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 15th, 2026
- Have $500? Invest in Elon’s AI Masterplan
- America’s 1776 happening again
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
